Risk factors and prognostic index model for pancreatic cancer
Open Access
- 1 January 2022
- journal article
- research article
- Published by AME Publishing Company in Gland Surgery
- Vol. 11 (1) , 186-195
Abstract
Risk factors and prognostic index model for pancreatic cancer Hui Huang, Jichun Sun, Zheming Jiang, Xianlin Zhang, Zheng Li, Hongwei Zhu, Xiao YuKeywords
This publication has 28 references indexed in Scilit:
- Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancerHPB, 2018
- Integrated Analysis of Long Non-Coding RNA and mRNA Expression Profile in Pancreatic Cancer Derived Exosomes Treated Dendritic Cells by Microarray AnalysisJournal of Cancer, 2018
- Neutrophil–lymphocyte ratio, platelet–lymphocyte ratio, neutrophil–platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?Current Medical Research and Opinion, 2017
- Tumor angiogenesis and vascular normalization: alternative therapeutic targetsAngiogenesis, 2017
- Early detection of pancreatic cancer: Where are we now and where are we going?International Journal of Cancer, 2017
- Predictors of Early Mortality After Surgical Resection of Pancreatic Adenocarcinoma in the Era of Neoadjuvant TreatmentPancreas, 2017
- The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patientsPancreatology, 2016
- Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: A meta-analysisWorld Journal of Gastroenterology, 2015
- Advanced pancreatic carcinoma: current treatment and future challengesNature Reviews Clinical Oncology, 2010
- Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological studyBritish Journal of Surgery, 1995